منابع مشابه
Sofosbuvir-velpatasvir for treating chronic hepatitis C.
On Jan 25, 2017, the UK National Institute for Health and Care Excellence (NICE) published guidance recommending sofosbuvirvelpatasvir (Gilead Sciences Ltd, Uxbridge, UK) as an option for treating chronic hepatitis C in adults (table), only if the manufacturing company provides the drug with the price reduction in the simple discount agreement. NICE appraised sofosbuvirvelpatasvir as a single t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Reactions Weekly
سال: 2021
ISSN: ['1179-2051', '0114-9954']
DOI: https://doi.org/10.1007/s40278-021-95301-4